echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Microbiology News > Transposon Mutagenesis in Clostridium difficile

    Transposon Mutagenesis in Clostridium difficile

    • Last Update: 2021-02-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Genetic manipulation of
    Clostridium difficile
    is notoriously difficult, currently there is only one reliable method for generating random mutations in the organism and that is to use the conjugative transposon Tn
    916
    . Tn
    916
    enters the genome of most strains of
    C. difficile
    with no obvious target site preference. In order to use the genome strain
    C. difficile
    630 for transposon mutagenesis a erythromycin-sensitive derivative
    C. difficile
    630Δ
    erm
    was constructed and the Tn
    916
    derivative, Tn
    916
    ΔE, was shown to enter the genome at multiple sites enabling the construction of a Tn
    916
    insertion library.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.